hematopoietic stem cells

Normal Hematopoiesis and Its Regulation

LECTURES , , , ,

Elena B. Vladimirsky

For correspondence: Elena B. Vladimirsky, DSci, Professor, Honored Scientist of Russia; Itamar Ben Avi str., 22/1, Jerusalem, Israel, 92348; Tel.: +972(0)2 650-96-82; e-mail: regblood3@yandex.ru

For citation: Vladimirsky EB. Normal Hematopoiesis and Its Regulation. Clinical oncohematology. 2015;8(2):109–19 (In Russ).

ABSTRACT

Normal hematopoiesis results in production of a great number of cells. The constancy of the qualitative and quantitative composition of the cell component of the hematopoietic system is maintained by the basic hematopoietic law: equal numbers of cell births and deaths occur within each time unit. This balance is provided by three levels of the hematopoietic system: stem cells, growth factors and stromal microenvironment. Hematopoietic stem cells (HSCs) can differentiate into all types of blood cells and at the same time proliferate to preserve the constant number of their pool since no replenishment from external sources occurs during the post-natal period. When the total HSCs count is reduced below the critical level (e.g., by chemotherapy or radiation), they stop differentiating, however they retain the ability for self-renewing until the standard level is reached again. This is the main cause of cytopenia after chemotherapy and radiation; it also explains high efficacy of stem cells transplanting in such cases. Hematopoietic growth factors — glycoproteins — are produced by several blood and stromal cells. The growth factors are essential for realization of any cell program, but the type of the program depends solely on the cell itself: expression of cytokine receptors, features of formation and conduction of cytokine signals, and genetic determination of the cell. The hematopoietic bone marrow cells are situated on spongy bone trabeculae covered with stromal tissue, which consists of cells and the intermediate substance produced by the cells. The hematopoietic function of the stroma is realized through specific adhesion of HSCs and production of growth factors and molecules of cell interaction. Stromal microenvironment also plays a leading role in selective migration of cells from the bone marrow to the circulation system. Evaluation of bone marrow aspirate smear is a very important diagnostic technique for assessment of hematopoiesis. So-called bone marrow indices, i.e. ratios between several types of hematopoietic cells (the myeloid/erythroid index; the index of neutrophil maturation; the index of red cell maturation) have been developed for this purpose. Assessment of these indices together with the bone marrow cellularity, peripheral blood count, and clinical data is very important for expert evaluation of the hematopoiesis and for drawing a proper diagnostic conclusion.

Keywords: hematopoietic stem cells, regulation of hematopoiesis, hematopoietic growth factors, stromal microenvironment, bone marrow indices.

Received: October 13, 2014

Accepted: January 27, 2015

Read in PDF (RUS)pdficon

REFERENCES

  1. Владимирская Е.Б. Механизмы кроветворения и лейкемогенеза. М.: Династия, 2007.
    [Vladimirskaya EB. Mekhanizmy krovetvoreniya i leikemogeneza. (Mechanisms of hematopoiesis and leukemogenesis). Moscow: Dinastia Publ.; 2007. (In Russ)]
  2. Дризе Н.И., Чертков И.Л. Стволовая кроветворная клетка. В кн.: Гериатрическая гематология. Заболевания системы крови в старших возрастных группах. Под ред. Л.Д. Гриншпун, А.В. Пивника. Т. 1. М.: Медиум, 2011. С. 11–20.
    [Drize NI, Chertkov IL. Hematopoietic stem cell. In: Grinshpun LD, Pivnik AV, eds. Geriatricheskaya gematologiya. Zabolevaniya sistemy krovi v starshikh vozrastnykh gruppakh (Geriatric hematology. Hematological diseases in elderly population). Vol. 1. Moscow: Medium Publ.; 2011. pp. 11–20. (In Russ)]
  3. Ningning He, Lu Zhang, Jian Cui, Zongjin Li. Bone marrow vascular niche: home for hematopoietic stem cells. Bone Marrow Res. 2014:128436. doi: 10.1155/2014/128436.
  4. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132(4):631–44. doi: 10.1016/j.cell.2008.01.025.
  5. Pietras EM, Warr MR, Passegue E. Cell cycle regulation in hematopoietic stem cells. J Cell Biol. 2011;195(5):709–20. doi: 10.1083/jcb.201102131.
  6. Ceredig R, Rolink AG, Brown G. Models of haematopoiesis: seeing the wood for the trees. Nat Rev Immunol. 2009;9(4):293–300. doi: 10.1038/nri2525.

Mixed chimerism following allogeneic bone marrow transplantation: cases report

BONE MARROW TRANSPLANTATION , , , ,

K.N. Melkova, N.V. Gorbunova, T.Z. Cherniavskaya

FSBI «N.N. Blokhin Russian Cancer Research Center» RAMS, Moscow, Russian Federation

ABSTRACT

Cimerism monitoring after the bone marrow transplantation (BMT) by a method based on the quantitative polymerase chain reaction (PCR), is important for the assessment of efficiency of transplantation, early identification of recurrence and timely correction of therapy. Clinical examples of the mixed chimerism after allogeneic BMT are presented.

Keywords: allogeneic transplantation, chimerism, mixed chimerism, bone marrow, hematopoietic stem cells.

Read in PDF (RUS)pdficon

REFERENCES

  1. Appelbaum F.R., Forman S. J., Negrin R.S., Blume K.G. Thomas’ Hematopoietic Cell Transplantation, 4th ed. Malden: Blackwell Publishing Ltd., 2009: 316–27.
  2. Blum W., Brown R., Lin H.-S. et al. Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: Consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity. Biol. Blood Marrow Transplant. 2002; 8(11): 608–18.
  3. Tutschka P.J., Copelan E.A., Klein J.P. Bone Marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70(5): 1382–8.
  4. Munker R., Lasarus H.M., Atkinson K. The BMT Data Book, 2nd ed. Cambridge University Press, 2009: 331–56.
  5. Matutes E., Pickl W.F., van’t Veer M. et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 2011; 117: 3163–71.
  6. Румянцев А.Г., Масчан А.А. Трансплантация гемопоэтических стволовых клеток у детей. М.: МИА, 2003: 405. [Rumyantsev A.G., Maschan A.A. Transplantatsiya gemopoeticheskikh stvolovykh kletok u detei (Hematopoietic stem cell transplantation in children). M.: MIA, 2003: 405.]